Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.

Möller I, Wintermeyer A, Bender K, Jübner M, Thomas A, Krug O, Schänzer W, Thevis M.

Drug Test Anal. 2011 Sep;3(9):609-20. doi: 10.1002/dta.158. Epub 2010 Sep 24.

PMID:
20872894
2.
3.

Prevalence of synthetic cannabinoids in U.S. athletes: initial findings.

Heltsley R, Shelby MK, Crouch DJ, Black DL, Robert TA, Marshall L, Bender CL, DePriest AZ, Colello MA.

J Anal Toxicol. 2012 Oct;36(8):588-93. doi: 10.1093/jat/bks066. Epub 2012 Aug 7.

PMID:
22872465
4.

High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.

Yanes EG, Lovett DP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 15;909:42-50. doi: 10.1016/j.jchromb.2012.10.013. Epub 2012 Oct 16.

PMID:
23153643
5.
6.

Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.

Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schänzer W, Thevis M.

Anal Bioanal Chem. 2011 Aug;401(2):493-505. doi: 10.1007/s00216-011-4931-5. Epub 2011 Apr 1.

PMID:
21455647
7.

Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.

Scheidweiler KB, Jarvis MJ, Huestis MA.

Anal Bioanal Chem. 2015 Jan;407(3):883-97. doi: 10.1007/s00216-014-8118-8. Epub 2014 Sep 16.

PMID:
25224637
8.

Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures.

Grigoryev A, Savchuk S, Melnik A, Moskaleva N, Dzhurko J, Ershov M, Nosyrev A, Vedenin A, Izotov B, Zabirova I, Rozhanets V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 May 1;879(15-16):1126-36. doi: 10.1016/j.jchromb.2011.03.034. Epub 2011 Mar 26.

PMID:
21481654
9.

A sensitive GC-EIMS method for simultaneous detection and quantification of JWH-018 and JWH-073 carboxylic acid and hydroxy metabolites in urine.

Paul BD, Bosy T.

J Anal Toxicol. 2015 Apr;39(3):172-82. doi: 10.1093/jat/bku178. Epub 2015 Feb 17.

PMID:
25691387
10.

Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?

Schaefer N, Helfer AG, Kettner M, Laschke MW, Schlote J, Ewald AH, Meyer MR, Menger MD, Maurer HH, Schmidt PH.

Drug Test Anal. 2017 Apr;9(4):613-625. doi: 10.1002/dta.1995. Epub 2016 Jun 22.

PMID:
27328899
11.

Detection Times of Carboxylic Acid Metabolites of the Synthetic Cannabinoids JWH-018 and JWH-073 in Human Urine.

Hegstad S, Westin AA, Spigset O.

J Anal Toxicol. 2015 May;39(4):280-6. doi: 10.1093/jat/bkv013. Epub 2015 Mar 3.

PMID:
25737323
12.

Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

Chimalakonda KC, Moran CL, Kennedy PD, Endres GW, Uzieblo A, Dobrowolski PJ, Fifer EK, Lapoint J, Nelson LS, Hoffman RS, James LP, Radominska-Pandya A, Moran JH.

Anal Chem. 2011 Aug 15;83(16):6381-8. doi: 10.1021/ac201377m. Epub 2011 Jul 27.

13.

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

Sobolevsky T, Prasolov I, Rodchenkov G.

Drug Test Anal. 2012 Oct;4(10):745-53. doi: 10.1002/dta.1418. Epub 2012 Oct 5.

PMID:
23042760
14.

Validation of JWH-018 and its metabolites in blood and urine by UPLC-MS/MS: Monitoring in forensic cases.

Erol Öztürk Y, Yeter O, Alpertunga B.

Forensic Sci Int. 2015 Mar;248:88-93. doi: 10.1016/j.forsciint.2014.12.029. Epub 2015 Jan 9.

PMID:
25616218
15.

Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS.

Kavanagh P, Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:102-8. doi: 10.1016/j.jchromb.2013.07.005. Epub 2013 Jul 15.

PMID:
23917406
16.

Validation and application of an UPLC-MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market.

Simões SS, Silva I, Ajenjo AC, Dias MJ.

Forensic Sci Int. 2014 Oct;243:117-25. doi: 10.1016/j.forsciint.2014.07.022. Epub 2014 Jul 27.

PMID:
25127518
17.

Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases.

Jang M, Yang W, Choi H, Chang H, Lee S, Kim E, Chung H.

Forensic Sci Int. 2013 Sep 10;231(1-3):13-9. doi: 10.1016/j.forsciint.2013.03.053. Epub 2013 May 14.

PMID:
23890611
18.

Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.

Gundersen POM, Spigset O, Josefsson M.

Drug Test Anal. 2019 Jan;11(1):51-67. doi: 10.1002/dta.2464. Epub 2018 Sep 8.

19.

Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.

Arntson A, Ofsa B, Lancaster D, Simon JR, McMullin M, Logan B.

J Anal Toxicol. 2013 Jun;37(5):284-90. doi: 10.1093/jat/bkt024. Epub 2013 Apr 26.

PMID:
23625703
20.

Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.

Franz F, Angerer V, Moosmann B, Auwärter V.

Drug Test Anal. 2017 May;9(5):744-753. doi: 10.1002/dta.2049. Epub 2016 Sep 21.

PMID:
27504870

Supplemental Content

Support Center